Mathers Edward T. - 31 Dec 2025 Form 4 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
Director
Signature
/s/ Zachary Bambach, attorney-in-fact
Issuer symbol
OKUR
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
02 Jan 2026, 16:16:56 UTC
Previous filing
06 Oct 2025
Next filing
05 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Mathers Edward T. filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 02 Jan 2026."

Quick Takeaways

  • This page summarizes Mathers Edward T.'s Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 02 Jan 2026, 16:16.

What Changed

  • Previous filing in this sequence was filed on 06 Oct 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mathers Edward T Director 104 5TH AVE, 19TH FLOOR, NEW YORK /s/ Zachary Bambach, attorney-in-fact 02 Jan 2026 0001328625

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OKUR Class A Common Stock Award $0 +3,911 +34% $0.000000 15,310 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are fully vested restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock. The RSUs were granted to the Reporting Person in lieu of a quarterly cash retainer, at the election of the Reporting Person, under the Issuer's Outside Director Compensation Policy.

Sponsored